GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Cartesian Growth Corp II (NAS:RENE) » Definitions » Research & Development

Cartesian Growth II (Cartesian Growth II) Research & Development : $0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cartesian Growth II Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Cartesian Growth II's Research & Development for the three months ended in Mar. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.


Cartesian Growth II Research & Development Historical Data

The historical data trend for Cartesian Growth II's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cartesian Growth II Research & Development Chart

Cartesian Growth II Annual Data
Trend Dec21 Dec22 Dec23
Research & Development
- - -

Cartesian Growth II Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cartesian Growth II Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cartesian Growth II  (NAS:RENE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Cartesian Growth II Research & Development Related Terms

Thank you for viewing the detailed overview of Cartesian Growth II's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Cartesian Growth II (Cartesian Growth II) Business Description

Traded in Other Exchanges
N/A
Address
505 Fifth Avenue, 15th Floor, New York, NY, USA, 10017
Cartesian Growth Corp II is a blank check company.
Executives
Peter Yu director, 10 percent owner, officer: See Remarks C/O CARTESIAN CAPITAL GROUP, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Pangaea Three-b, Lp 10 percent owner C/O CARTESIAN CAPITAL GROUP, 505 FIFTH AVE., 15TH FLOOR, NEW YORK NY 10017
Bertrand P. Grabowski director C/O CARTESIAN GROWTH CORPORATION, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Daniel Jeremy Karp director C/O CARTESIAN GROWTH CORPORATION, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Beth Michelson officer: Chief Financial Officer C/O CARTESIAN GROWTH CORPORATION II, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Cgc Ii Sponsor Llc 10 percent owner C/O CARTESIAN GROWTH CORPORATION II, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Luque Rafael De director C/O CARTESIAN GROWTH CORPORATION II, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Sheryl Schwartz director C/O CARTESIAN GROWTH CORPORATION II, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Allan Leighton director C/O CARTESIAN GROWTH CORPORATION II, NEW YORK NY 10017

Cartesian Growth II (Cartesian Growth II) Headlines